Antimicrobial drug resistance in Taiwan

International Journal of Antimicrobial Agents

Volumn 32, Issue SUPPL. 3, 2008, Pages

  Huang, Yu Tsung ^a   Hsueh, Po Ren ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Antimicrobial resistance; Epidemiology; Taiwan

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN; AMPHOTERICIN B; AZITHROMYCIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; ETHAMBUTOL; EXTENDED SPECTRUM BETA LACTAMASE; FLUCONAZOLE; IMIPENEM; ISONIAZID; ITRACONAZOLE; MACROLIDE; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; TELITHROMYCIN; TETRACYCLINE; VORICONAZOLE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASIA; ASPERGILLUS FLAVUS; BACTERIAL GENETICS; BACTERIAL INFECTION; BACTERIUM ISOLATE; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA TROPICALIS; DISK DIFFUSION; DRUG SURVEILLANCE PROGRAM; DRUG USE; ENTEROBACTERIACEAE; EPIDEMIOLOGY; GEOGRAPHIC DISTRIBUTION; HAEMOPHILUS INFLUENZAE; HOSPITAL INFECTION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MYCOBACTERIUM TUBERCULOSIS; NEISSERIA GONORRHOEAE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SALMONELLA CHOLERAESUIS; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; TAIWAN; TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; TAIWAN;

EID: 55649099597     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(08)70023-2     Document Type: Article

References (54)

1. Song J.H., Jung S.I., Ko K.S., Kim N.Y., Son J.S., Chang H.H., et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolate in Asia (an ANSORP study). Antimicrob Agents Chemother 48 (2004) 2101-2107
2. Hsueh P.R. Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic usage in Taiwan. Clin Microbiol Infect 11 (2005) 925-927
3. Tristram S., Jacobs M.R., and Appelbaum P.C. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev 20 (2007) 368-389
4. Hotomi M., Fujihara K., Billal D.S., Suzuki K., Nishimura T., Baba S., et al. Genetic characteristics and clonal dissemination of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains isolated from the upper respiratory tract of patients in Japan. Antimicrob Agents Chemother 51 (2007) 3969-3976
5. Hsueh P.R., Liu Y.C., Shyr J.M., Wu T.L., Yan J.J., Wu J.J., et al. Multicenter surveillance of antimicrobial resistance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan during the 1998-1999 respiratory season. Antimicrob Agents Chemother 44 (2000) 1342-1345
6. Hoban D., and Felmingham D. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections. J Antimicrob Chemother 50 Suppl S1 (2002) 49-59
7. Cantón R., Loza E., Morosini M.I., and Baquero F. Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000. J Antimicrob Chemother 50 Suppl S1 (2002) 9-24
8. Hsueh P.R., Teng L.J., Lee C.M., Huang W.K., Wu T.L., Wan J.H., et al. Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes : SMART Program 2001 Data. Antimicrob Agents Chemother 47 (2003) 2152-2157
9. Beekmann S.E., Heilmann K.P., Richter S.S., Garcí-de-Lomas J., Doern G.V., and The GRASP Study Group. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program. Int J Antimicrob Agents 25 (2005) 148-156
10. Chang S.C., Chen Y.C., Luh K.T., and Hsieh W.C. Macrolides resistance of common bacteria isolated from Taiwan. Diagn Microbiol Infect Dis 23 (1995) 147-154
11. Hsueh P.R., Chen H.M., Huang A.H., and Wu J.J. Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob Agents Chemother 39 (1995) 2239-2242
12. Hsueh P.R., Shyr J.M., and Wu J.J. Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococ- cus pyogenes in Taiwan. Clin Infect Dis 40 (2005) 903-905
13. Chiu C.H., Wu T.L., Su L.H., Chu C., Chia J.H., Kuo A.J., et al. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis. N Engl J Med 346 (2002) 413-419
14. Chiu C.H., Su L.H., and Chu C. Salmonella enterica serotype Choleraesuis: epidemiology, pathogenesis, clinical disease, and treatment. Clin Microbiol Rev 17 (2004) 311-322
15. Hsueh P.R., Teng L.J., Tseng S.P., Chang C.F., Wan J.H., Yan J.J., et al. Ciprofloxacin- resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan. Emerg Infect Dis 10 (2004) 60-68
16. Yan J.J., Chiou C.S., Lauderdale T.L., Tsai S.H., and Wu J.J. Cephalosporin and ciprofloxacin resistance in Salmonella, Taiwan. Emerg Infect Dis 11 (2005) 947-950
17. Boucher H.W., and Corey G.R. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 46 Suppl 5 (2008) S344-S349
18. Wu K.C., Chiu H.H., Wang J.H., Lee N.S., Lin H.C., Hsieh C.C., et al. Characteristics of community-acquired methicillin-resistant Staphylococcus aureus in infants and children without known risk factors. J Microbiol Immunol Infect 35 (2002) 53-56
19. Boyle-Vavra S., Ereshefsky B., Wang C.C., and Daum R.S. Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel staphylococcal chromosome cassette mec (SCCmec) type VT or SCCmec type IV. J Clin Microbiol 43 (2005) 4719-4730
20. Matsumoto T. Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae. Int J Antimicrob Agents 31 Suppl 1 (2008) S35-S39
21. Hsueh P.R., Tseng S.P., Teng L.J., and Ho S.W. High prevalence of ciprofloxacin-resistant Neisseria gonorrhoeae in Northern Taiwan. Clin Infect Dis 40 (2005) 188-192
22. Su X., Jiang F., Qimuge, Dai X., Sun H., and Ye S. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006. Sex Transm Dis 34 (2007) 995-999
23. Bala M., Jain R.K., and Ray K. Antimicrobial susceptibility profile of resistance phenotypes of Neisseria gonorrhoeae in India. Sex Transm Dis 35 (2008) 588-591
24. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: M100-S18; 18th informational supplement (2008), Clinical and Laboratory Standards Institute, Wayne, PA
25. Hirakata Y., Matsuda J., Miyazaki Y., Kamihira S., Kawakami S., Miyazawa Y., et al. Regional variation in the prevalence of extended-spectrum beta-lactamase- producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn Microbiol Infect Dis 52 (2005) 323-329
26. Paterson D.L., and Bonomo R.A. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18 (2005) 657-686
27. Hawkey P.M. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect 14 Suppl 1 (2008) 159-165
28. Yu W.L., Chuang Y.C., and Walther-Rasmussen J. Extended-spectrum beta- lactamases in Taiwan: epidemiology, detection, treatment and infection control. J Microbiol Immunol Infect 39 (2006) 264-277
29. Hsueh P.R., Liu C.Y., and Luh K.T. Current status of antimicrobial resistance in Taiwan. Emerg Infect Dis 8 (2002) 132-137
30. Hadadi A., Rasoulinejad M., Maleki Z., Yonesian M., Shirani A., and Kourorian Z. Antimicrobial resistance pattern of Gram-negative bacilli of nosocomial origin at 2 university hospitals in Iran. Diagn Microbiol Infect Dis 60 (2008) 301-305
31. Ishii Y., and Yamaguchi K. Evaluation of the susceptibility trends to meropenem in a nationwide collection of clinical isolates in Japan: a longitudinal analysis from 2002 to 2006. Diagn Microbiol Infect Dis 61 (2008) 346-350
32. Walsh T.R., Toleman M.A., Poirel L., and Nordmann P. Metallo-beta-lactamases: the quiet before the storm?. Clin Microbiol Rev 18 (2005) 306-325
33. Yan J.J., Hsueh P.R., Ko W.C., Luh K.T., Tsai S.H., and Wu H.M. Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother 45 (2001) 2224-2228
34. Huang Y.T., Chang S.C., Lauderdale T.L., Yang A.J., and Wang J.T. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase genes in Taiwan. Diagn Microbiol Infect Dis 59 (2007) 211-216
35. Yu Y.S., Qu T.T., Zhou J.Y., Wang J., Li H.Y., and Walsh T.R. Integrons containing the VIM-2 metallo-beta-lactamase gene among imipenem-resistant Pseudomonas aeruginosa strains from different Chinese hospitals. J Clin Microbiol 44 (2006) 4242-4245
36. Dijkshoorn L., Nemec A., and Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5 (2007) 939-951
37. Reinert R.R., Low D.E., Rossi F., Zhang X., Wattal C., and Dowzicky M.J. Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J Antimicrob Chemother 60 (2007) 1018-1029
38. Kuo L.C., Yu C.J., Kuo M.L., Chen W.N., Chang C.K., Lin H.I., et al. Antimicrobial resistance of bacterial isolates from respiratory care wards in Taiwan: a horizontal surveillance study. Int J Antimicrob Agents 31 (2008) 420-426
39. Hsueh P.R., Teng L.J., Chen W.H., Pan H.J., Chen M.L., Chang S.C., et al. Increasing prevalence of methicillin-resistant Staphylococcus aureus causing nosocomial infections at a university hospital in Taiwan from 1986 to 2001. Antimicrob Agents Chemother 48 (2004) 1361-1364
40. Hsueh P.R., Chen W.H., Teng L.J., and Luh K.T. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents. Int J Antimicrob Agents 26 (2005) 43-49
41. Luh K.T., Hsueh P.R., Teng L.J., Pan H.J., Chen Y.C., Lu J.J., et al. Quinupristin- dalfopristin resistance among Gram-positive bacteria in Taiwan. Antimicrob Agents Chemother 44 (2000) 3374-3380
42. Biedenbach D.J., Bell J.M., Sader H.S., Fritsche T.R., Jones R.N., and Turnidge J.D. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Int J Antimicrob Agents 30 (2007) 143-149
43. Hiramatsu K., Aritaka N., Hanaki H., Kawasaki S., Hosoda Y., Hori S., et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350 (1997) 1670-1673
44. Kim H.B., Jang H.C., Nam H.J., Lee Y.S., Kim B.S., Park W.B., et al. In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary- care hospitals in Korea: a nationwide survey. Antimicrob Agents Chemother 48 (2004) 1124-1127
45. Trakulsomboon S., Danchaivijitr S., Rongrungruang Y., Dhiraputra C., Susaemgrat W., Ito T., et al. First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand. J Clin Microbiol 39 (2001) 591-595
46. Wang J.L., Tseng S.P., Hsueh P.R., and Hiramatsu K. Vancomycin heteroresistance in methicillin-resistant Staphylococcus aureus, Taiwan. Emerg Infect Dis 10 (2004) 1702-1704
47. Song J.H., Hiramatsu K., Suh J.Y., Ko K.S., Ito T., Kapi M., et al. Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 48 (2004) 4926-4928
48. Hsueh P.R., Liu Y.C., Yang D., Yan J.J., Wu T.L., Huang W.K., et al. Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microb Drug Resist 7 (2001) 345-354
49. Lu J.J., Perng C.L., Ho M.F., Chiueh T.S., and Lee W.H. High prevalence of vanB2 vancomycin resistant Enterococcus faecium in Taiwan. J Clin Microbiol 39 (2001) 2140-2145
50. Hsueh P.R., Liu Y.C., So J., Liu C.Y., Yang P.C., and Luh K.T. Mycobacterium tuberculosis in Taiwan. J Infect 52 (2006) 77-85
51. Lai CC, Tan CK, Huang YT, Chou CH, Hung CC, Yang PC, et al. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a medical center in Taiwan. Clin Infect Dis. Forthcoming 2008.
52. Pfaller M.A., Diekema D.J., Gibbs D.L., Newell V.A., Meis J.F., Gould I.M., et al. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 45 (2007) 1735-1745
53. Hsueh P.R., Lau Y.J., Chuang Y.C., Wan J.H., Huang W.K., Shyr J.M., et al. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003. Antimicrob Agents Chemother 49 (2005) 512-517
54. Ruan S.Y., Chu C.C., and Hsueh P.R. In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible- dose dependent Candida glabrata isolates. Antimicrob Agents Chemother 52 (2008) 2919-2922